TRANSCEND FL: Phase II Study Results of Lisocabtagene Maraleucel (Liso-Cel) in Patients With R/R Follicular Lymphoma (FL)

Nastoupil, LJ; Dahiya, S; Palomba, ML; Garcia-Sancho, AM; Ortega, JLR; Kuruvilla, J; Jager, U; Cartron, G; Izutsu, KI; Dreyling, M; Kahl, B; Ghesquieres, H; Ardeshna, K; Goto, H; Barbui, AM; Abramson, JS; Borchmann, P; Fleury, I; Mielke, S; Farazi, T; Fasan, O; Lymp, J; Vedal, M; Nishii, R; Avilion, A; Papuga, J; Morschhauser, F

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023; 23 (): S447